Houston Methodist Research Institute

The trials here

What the 30 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials
• Bladder cancer2 trials
• High blood pressure2 trials
• HIV2 trials
• Liver and biliary tract cancer2 trials
• Prostate cancer2 trials
• Stroke2 trials
• Type 2 diabetes2 trials
• ALS (motor neurone disease)1 trial
• Aortic aneurysm1 trial
• Atrial fibrillation1 trial
• Chronic kidney disease1 trial
• and 12 more

Phase

• Phase 24 trials
• Phase 34 trials
• Phase 13 trials
• Phase 1/22 trials
• Phase 41 trial

Status

• Completed10 trials
• Recruiting9 trials
• Active, not recruiting8 trials
• Enrolling by invitation1 trial
• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• The Methodist Hospital Research Institute7 trials
• Johns Hopkins University2 trials
• Bayer1 trial
• Boston Scientific Corporation1 trial
• Century Therapeutics, Inc.1 trial
• and 18 more

Running trials

• Recruiting

  Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

  NCT07665372· Johns Hopkins University· Source

  Contact: Masayuki Nigo, MD MSc

• Recruiting

  Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease

  NCT07651319· Phase 1/2· The Methodist Hospital Research Institute· Source

  Contact: Alireza Faridar, MD

• Recruiting

  Non-invasive VNS in Stroke Recovery

  NCT06761404· The Methodist Hospital Research Institute· Source

  Contact: Darrel Cleere

• Active, not recruiting

  Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

  NCT05839730· Medtronic Cardiac Rhythm and Heart Failure· Source

• Recruiting

  Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

  NCT06263426· Johns Hopkins University· Source

  Contact: Kevin Grimes, MD, MPH

• Active, not recruiting

  Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

  NCT06267391· Endogenex, Inc.· Source

• Recruiting

  SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

  NCT06001827· VenoStent· Source

  Contact: Caroline Antunes

• Active, not recruiting

  A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

  NCT06111235· Phase 3· CG Oncology, Inc.· Source

• Enrolling by invitation

  Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria

  NCT05185505· Phase 4· The Methodist Hospital Research Institute· Source

• Recruiting

  Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease

  NCT05582200· The Methodist Hospital Research Institute· Source

  Contact: Joseph C. Masdeu, MD, PhD

• Active, not recruiting

  P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma

  NCT04960579· Phase 1· Poseida Therapeutics, Inc.· Source

• Active, not recruiting

  A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

  NCT05243550· Phase 3· UroGen Pharma Ltd.· Source

• Recruiting

  JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

  NCT05064540· Endologix· Source

  Contact: Solange Basagoitia

• Active, not recruiting

  da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures

  NCT04403022· Intuitive Surgical· Source

• Recruiting

  Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

  NCT04916210· Massachusetts General Hospital· Source

  Contact: Rajan Gadhia, MD

• Recruiting

  Ocrelizumab for Psychosis by Autoimmunity

  NCT03971487· Phase 1/2· The Methodist Hospital Research Institute· Source

  Contact: Nilene M Crisci, RN

• Active, not recruiting

  A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

  NCT03574571· Phase 3· Memorial Sloan Kettering Cancer Center· Source

• Active, not recruiting

  ADAPT - A Patient Registry of the Real-world Use of Orenitram®

  NCT03045029· United Therapeutics· Source

• Recruiting

  Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

  NCT02071134· Boston Scientific Corporation· Source

  Contact: Boston Scientific Clinical Research

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• HIV2 recruiting
• Stroke2 recruiting
• Aortic aneurysm1 recruiting
• Chronic kidney disease1 recruiting
• Liver and biliary tract cancer1 recruiting
• Parkinson disease1 recruiting
• Schizophrenia1 recruiting
• Vascular dementia1 recruiting

Closed trials

• Completed

  Assessment of the Safety and Efficacy of the Felix NeuroAI Wristband in Essential Tremor

  NCT06235190· Fasikl Inc.· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

  NCT05832151· Phase 2· CinDome Pharma, Inc.· Source

• Completed

  Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion

  NCT05477147· Volta Medical· Source

• Completed

  A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

  NCT05769608· Phase 2· Mineralys Therapeutics Inc.· Source

• Terminated

  A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

  NCT05336409· Phase 1· Century Therapeutics, Inc.· Source

• Completed

  Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

  NCT05171335· Phase 2· The Methodist Hospital Research Institute· Source

• Completed

  In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes

  NCT05238142· Medtronic MiniMed, Inc.· Source

• Completed

  A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.

  NCT05059236· Phase 2· Bayer· Source

• Completed

  Study in ALS With Abatacept & IL-2

  NCT06307301· Phase 1· The Methodist Hospital Research Institute· Source

• Completed

  A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

  NCT04083235· Phase 3· Ipsen· Source

• Completed

  Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli

  NCT03946072· University of California, San Francisco· Source